Your search returned 3 results.

Results
	1.	A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. [electronic resource] by Jatoi, A Steen, P D Atherton, P J Moore, D F Rowland, K M Le-Lindqwister, N A Adonizio, C S Jaslowski, A J Sloan, J Loprinzi, C Producer: 20180507 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. [electronic resource] by Smith, E M L Pang, H Ye, C Cirrincione, C Fleishman, S Paskett, E D Ahles, T Bressler, L R Le-Lindqwister, N Fadul, C E Loprinzi, C Shapiro, C L Producer: 20171004 In: European journal of cancer care vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer. [electronic resource] by Perez, E A Hillman, D W Dentchev, T Le-Lindqwister, N A Geeraerts, L H Fitch, T R Liu, H Graham, D L Kahanic, S P Gross, H M Patel, T A Palmieri, F M Dueck, A C Producer: 20100506 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)